Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

por Cummins, K D, Jane, S M, Ninkovic, S, Bazargan, A, Filshie, R, Sutrave, G, Hertzberg, M, Scott, A, Lane, S, Yannakou, C K, Ritchie, D, D'Rozario, J, Black, J, Bavishi, K, Wei, A
Publicado 2014

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

por Cummins, K D, Jane, S M, Nikovic, S, Bazargan, A, Filshie, R, Sutrave, G, Hertzberg, M, Scott, A, Lane, S, Yannakou, C K, Ritchie, D, D'Rozario, J, Black, J, Bavishi, K, Wei, A
Publicado 2014